Gene Review:
VIPR2 - vasoactive intestinal peptide receptor 2
Homo sapiens
Synonyms:
C16DUPq36.3, DUP7q36.3, Helodermin-preferring VIP receptor, PACAP type III receptor, PACAP-R-3, ...
- Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang, S., Kopras, E., McMichael, M., Bell, R.H., Ulrich, C.D. Cancer Res. (1997)
- VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Vertongen, P., Camby, I., Darro, F., Kiss, R., Robberecht, P. Neuropeptides (1996)
- Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors. Xia, M., Gaufo, G.O., Wang, Q., Sreedharan, S.P., Goetzl, E.J. J. Immunol. (1996)
- Localization of the VIP2 receptor protein on GnRH neurons in the female rat. Smith, M.J., Jiennes, L., Wise, P.M. Endocrinology (2000)
- Selective labeling and isolation of functional classes of interstitial cells of Cajal of human and murine small intestine. Chen, H., Redelman, D., Ro, S., Ward, S.M., Ord??g, T., Sanders, K.M. Am. J. Physiol., Cell Physiol. (2007)
- Structure of the human VIPR2 gene for vasoactive intestinal peptide receptor type 2. Lutz, E.M., Shen, S., Mackay, M., West, K., Harmar, A.J. FEBS Lett. (1999)
- Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene: a possible contributor to the holoprosencephaly 3 phenotype. Mackay, M., Fantes, J., Scherer, S., Boyle, S., West, K., Tsui, L.C., Belloni, E., Lutz, E., Van Heyningen, V., Harmar, A.J. Genomics (1996)
- Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood. Frühwald, M.C., O'Dorisio, M.S., Fleitz, J., Pietsch, T., Reubi, J.C. Int. J. Cancer (1999)
- Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Goetzl, E.J., Pankhaniya, R.R., Gaufo, G.O., Mu, Y., Xia, M., Sreedharan, S.P. Ann. N. Y. Acad. Sci. (1998)
- Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. Wei, Y., Mojsov, S. J. Neuroendocrinol. (1996)
- Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Adamou, J.E., Aiyar, N., Van Horn, S., Elshourbagy, N.A. Biochem. Biophys. Res. Commun. (1995)
- Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study. Lundeberg, L., Nordlind, K. Arch. Dermatol. Res. (1999)
- Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. Xia, M., Sreedharan, S.P., Bolin, D.R., Gaufo, G.O., Goetzl, E.J. J. Pharmacol. Exp. Ther. (1997)
- Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR). Nagakawa, O., Murata, J., Junicho, A., Matsuda, T., Fujiuchi, Y., Fuse, H., Saiki, I. Cancer Lett. (2002)
- Characterization of the VIP receptor from SUP T1 lymphoblasts. Robberecht, P., Gourlet, P., Vertongen, P., Svoboda, M. Adv. Neuroimmunol. (1996)